Spyre Therapeutics, Inc.
SYRE
$23.78
-$0.68-2.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -6.77% | -6.35% | 45.59% | -2.76% | -12.10% |
| Total Receivables | 2.94% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 465.37% | -71.26% | 4.54% | -47.11% | 270.10% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.43% | -6.36% | 44.50% | -3.36% | -10.58% |
|
|
|||||
| Total Current Assets | -5.43% | -6.36% | 44.50% | -3.36% | -10.58% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 0.00% | 0.00% | -96.98% | 0.61% |
| Total Assets | -5.43% | -6.36% | 44.50% | -3.43% | -10.57% |
|
|
|||||
| Total Accounts Payable | 0.62% | 453.90% | -87.11% | 59.86% | 4.02% |
| Total Accrued Expenses | -10.24% | -20.79% | 86.38% | 56.17% | -74.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 32.13% | 73.89% | -30.85% | 296.73% | 267.10% |
| Total Other Current Liabilities | 32.13% | 73.89% | -30.85% | 296.73% | 267.10% |
| Total Current Liabilities | 17.52% | 30.74% | -6.05% | 160.10% | -48.33% |
|
|
|||||
| Total Current Liabilities | 17.52% | 30.74% | -6.05% | 160.10% | -48.33% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -54.97% | 1.27% | -8.59% | -86.48% |
| Total Liabilities | -4.71% | -3.87% | -3.22% | 51.91% | -81.61% |
|
|
|||||
| Common Stock & APIC | 0.75% | 0.68% | 22.83% | 1.88% | 37.40% |
| Retained Earnings | -3.61% | -4.60% | -6.14% | -8.15% | -4.80% |
| Treasury Stock & Other | -33.43% | 278.89% | -87.65% | 363.47% | -52.34% |
| Total Common Equity | -8.21% | -9.72% | 110.98% | -21.50% | 769.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | -15.74% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -15.74% |
|
|
|||||
| Total Common Equity | -8.21% | -9.72% | 110.98% | -21.50% | 769.25% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | -15.74% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.56% | -6.80% | 58.16% | -12.55% | 145.87% |
|
|
|||||